Associate
Trevor Thompson is an associate in the Washington, D.C. office of Latham & Watkins.
Trevor advises pharmaceutical, biotechnology, medical device, digital health, tobacco, food product companies, and more on a wide array of regulatory, transactional, litigation, and legislative matters involving the Food and Drug Administration (FDA) and other federal and state regulatory bodies. He helps clients in these sectors evaluate regulatory risks and address and resolve pressing regulatory issues, ensuring compliance with complex regulatory frameworks while optimizing and maximizing strategic business opportunities. Trevor supports clients throughout the entire product lifecycle, from pre-market regulatory interactions and product submissions to post-market compliance, clinical and pre-clinical testing, product promotion and labeling, regulatory inspections, product manufacturing and quality issues, and regulatory exclusivity, among other areas.